Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-01

Clinical Trial Update: Safety and Efficacy of Urtica Dioica Cataplasm in the Management of Osgood-Schlatter Disease in Young Athletes [NA]

View source ↗

Summary

Clinical trial evaluating the safety and efficacy of Urtica Dioica Cataplasm for managing Osgood-Schlatter disease in young athletes; the study status is not ye…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Urtica Dioica Cataplasm

Snippet

Sponsor: Faculty of Medicine, Sousse | Conditions: Osgood-Schlatter Disease | NA | Status: NOT_YET_RECRUITING